stock
TOI · Starling Oncology, Inc.
What Starling Oncology, Inc. reports to the SEC, read from its filings.
Open in the appPrice
The live TOI price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on TOI.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 101,916,115 as of 2026-07-30 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- -4.4%
- Net
- 10324.6%
Returns
- ROE
- —
- ROA
- 34017.4%
Health
- Current ratio
- 1.4x
- Debt/equity
- —
Deep value
- NCAV
- -$74.16M
- NCAV per share
- -$0.73
- Price/NCAV
- Locked
- NNWC
- -$102.29M
- NNWC per share
- -$1.00
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | $161.28M | —Gross profit: unreported by this company. | -$4.62M | -$9.79M | 10-Q filed 2026-08-06 |
| 2026-03-31 | $147.44M | —Gross profit: unreported by this company. | -$6.51M | -$2.49M | 10-Q filed 2026-08-06 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-12-31 | $141.96M | —Gross profit: unreported by this company. | -$6.91M | $60.66B | DEF 14A filed 2026-04-30 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-09-30 | $136.56M | —Gross profit: unreported by this company. | -$8.05M | -$16.50M | 10-Q filed 2025-11-13 |
| 2025-06-30 | $119.80M | —Gross profit: unreported by this company. | -$11.21M | -$17.01M | 10-Q filed 2026-08-06 |
| 2025-03-31 | $104.41M | —Gross profit: unreported by this company. | -$9.91M | -$19.59M | 10-Q filed 2026-08-06 Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-12-31 | $100.27M | —Gross profit: unreported by this company. | -$11.93M | $64.71B | DEF 14A filed 2026-04-30 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-09-30 | $99.90M | —Gross profit: unreported by this company. | -$13.85M | -$16.11M | 10-Q filed 2025-11-13 |
- Assets
- $178.23M
- Equity
- -$24.91M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $502.73M | -$36.08M | $60.61B | -$27.79M |
| 2024-12-31 | $393.41M | -$60.12M | $64.66B | -$30.33M |
| 2023-12-31 | $324.24M | -$77.02M | -$83.07M | -$40.88M |
| 2022-12-31 | $252.48M | -$81.95M | $152,000 | -$67.28M |
| 2021-12-31 | $203.00M | -$45.86M | -$10.93M | -$35.53M |
| 2020-12-31 | $187.51M | -$8.20M | -$14.32M | -$686,000 |
Company filings
events
Executive or director change
Executive or director changeSep 18-KMaterial agreement, New debt
Material agreementNew debtAug 218-KResults
ResultsAug 68-KBylaws or fiscal year change, Regulation FD disclosure
Bylaws or fiscal year changeRegulation FD disclosureAug 38-KMaterial agreement, New debt, Unregistered share sale, Regulation FD disclosure
Material agreementNew debtUnregistered share saleRegulation FD disclosureJul 78-KShareholder vote results
Shareholder vote resultsJun 188-K
5% owners ()
M33 Growth I L.P.
Stake update
Chernett Jorey
Stake update
Chernett Jorey
Passive stake
M33 Growth I LP
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
Chernett Jorey
10% owner
Buy$94,860Jul 22, 9:55 AM ET
Podnos Yale
Chief Medical Officer
Sale$150,340Jul 16, 8:05 PM ET
Chernett Jorey
10% owner
Buy$87,750Jul 13, 11:34 AM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
None of the tracked funds held this at their last 13F.
News
Stories that named TOI, and the market events around them.
Sign in to see thisBoard
Recent signals
Signals open up here once a member has posted about TOI.
Signals are informational.
Posts · 0
No posts yet.
nakagai
Signals on TOI come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the TOI board